Effect of Continuous Intra Arterial Weak Bicarbonate Infusion on the Use of Fluid and Bicarbonate Boluses to Correct Metabolic Acidosis in Babies Weighing Less than 1000 g and Who are Less than 32 Weeks Gestation at Birth

• Register: ISRCTN
• Last refreshed on: 12 February 2013
• Main ID: ISRCTN22535466
• Date of registration: 30/09/2004
• Primary sponsor: Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
• Public title: Effect of Continuous Intra Arterial Weak Bicarbonate Infusion on the Use of Fluid and Bicarbonate Boluses to Correct Metabolic Acidosis in Babies Weighing Less than 1000 g and Who are Less than 32 Weeks Gestation at Birth N/A
• Date of first enrolment: Oct 30 2001
• Target sample size: Not provided at time of registration
• Recruitment status: Completed/Not recruiting
• URL: http://isrctn.org/ISRCTN22535466
• Study type: Interventional
• Study design: Randomised controlled trial

Countries of recruitment

United Kingdom

Contacts

• Name: Fiona Weir

Key inclusion & exclusion criteria

Inclusion criteria: Babies 32 weeks gestational age weighing <1000 g
Exclusion criteria: Does not meet inclusion criteria

Age minimum:
Age maximum:
Gender:

Health Condition(s) or Problem(s) studied

Neonatal Diseases: Metabolic acidosis

Intervention(s)

Randomised controlled trial

Primary Outcome(s)

Continuous weak alkali infusion may prevent acidosis from occurring and reduce the need for boluses of fluid or bicarbonate.

Secondary Outcome(s)

Not provided at time of registration

Secondary ID(s)

N0051113384

Source(s) of Monetary Support

Brighton and Sussex University Hospitals NHS Trust (UK)

Secondary Sponsor(s)

N/A